Home Clinical Trial Updates

Clinical Trial Updates

Human kidney cross section. Photo courtesy: 2019 Fotolia

Tivozanib Improved PFS and was better Tolerated Compared with Sorafenib in...

Peter Hofland, Ph.D -
Glioblastoma with extreme nuclear enlargement.

Tasadenoturev + Pembrolizumab Shows Clinical Benefit in Recurrent Glioblastoma

Peter Hofland, Ph.D -
Featured Image: Diffuse intrinsic pontine glioma (DIPG) is a rare, deadly childhood brain cancer. Here, a confocal micrograph shows DIPG cells, grown from patient cells, in culture. The cells are expressing several proteins, including: DAPI (blue, in the cell nuclei); vimentin (red, a protein marker of neural stem/precursor cells and glioma cells); and Nestin (green, also a protein marker of neural stem/precursor cells and glioma cells). Photo Courtesy: Shawn Gillespie, Monje Laboratory, Stanford Medicine.

Drug Combination Shows Promise Against Lethal Childhood Brain Cancers

Peter Hofland, Ph.D -
Doctor talking a with patient in hospital exam room. Photo courtesy: 2019 Fotolia

Phase III HERO Study of Oral Relugolix in Advanced Prostate Cancer...

Peter Hofland, Ph.D -
Images from Athens, Greece.The Porch of Maidens (Caryatids), an example of classical Greek architecture constructed between 421 BCE and 405 BCE. Caryatids are female figures and most likely represent the young women of Caryae, where there was a sanctuary of Artemis Caryatis (Artemis of the Walnut Tree). Photo Courtesy 2019 Fotolia.

Trabectedin Shows Favorable Results in Routine Real-life Clinical Practice in ...

Peter Hofland, Ph.D -

Study Confirms Racial Disparities in Treatment of Multiple Myeloma Patients

Peter Hofland, Ph.D -

HER2-Targeted Bispecific Antibody ZW25 Shows Durable Response

Peter Hofland, Ph.D -
Senior woman with lung cancer during medical visit

WCLC 2019: Updates from the Pembrolizumab Clinical Development Program

Peter Hofland, Ph.D -

Pembrolizumab + Chemotherapy meets Primary Endpoint in Pivotal Phase III Trial...

Peter Hofland, Ph.D -
Nader Sanai, MD, an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors and director of the Ivy Brain Tumor Center in Phoenix, Arizona, and a member of his clinical development team.

New Breast Cancer Drug has the Potential to be a Novel...

Peter Hofland, Ph.D -
123...18Page 1 of 18

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.